2019: Building a Health Plan Around What People Actually Do | Tami Wilson-Ciranna. CFO, Curative
Tammy Wilson-Serrana, CFO and President of Curative, discusses the company's transformation from a COVID testing provider to a health insurance company offering zero deductibles and zero copays. She emphasizes how removing financial barriers to care can reduce overall healthcare costs through preventive care engagement, supported by data-driven operations and AI integration.
Summary
Tammy Wilson-Serrana shares her career journey from Arthur Anderson partner through roles in commercial real estate and biotech before joining Curative in April 2020 on a three-month contract that extended to a permanent transformation of the company. She describes how her experiences in public accounting, Prolacta Bioscience, and Commonwealth Partners prepared her for leadership roles emphasizing execution, consistency, and building organizational structures rather than relying on singular great ideas.
The core of Curative's business model centers on a novel health insurance approach: zero deductibles, zero copays for in-network care, and mandatory baseline visits within 120 days of enrollment. Wilson-Serrana explains that this model removes financial barriers that traditionally deter people from seeking preventive care and filling prescriptions. She notes that 97% of pharmacy fills occur at zero copay by placing one drug from each class at no cost, including expensive medications without biosimilars. The philosophy is that if patients need medications or care, cost should not be a deterrent to engagement.
The company pivoted from pandemic testing (36 million tests conducted) to health insurance because, as Wilson-Serrana states, "what people pay for, people do, and what they don't pay for, people don't do." This required rolling $500 million from prior capital raises into the insurance startup to maintain an A- AMBEST rating. The revenue model operates on standard actuarial pricing based on premiums, member engagement, manual rating by risk factors and geography, and claims management.
Wilson-Serrana details key performance metrics the company monitors: medical loss ratio by county and geography, network provider costs, and wellness program efficacy. She emphasizes data-driven decision-making and the willingness to abandon assumptions when market feedback contradicts them, such as discovering that clients needed three plan options rather than the single zero-deductible plan initially offered.
AI implementation across Curative has addressed multiple operational challenges. In credentialing, an AI agent reduced processing time from six months to 24-48 hours, replacing an outsourced Philippines-based operation. In finance, AI enables customized analytics on large datasets, automated coding to appropriate GL accounts, and streamlined business intelligence and variance analysis processes. She notes that AI allows people to ask questions and drill down only when results appear problematic.
A critical strategic insight Wilson-Serrana shares involves state market expansion. Rather than concentrating in a single state, she recognized that entering a market requires three years: year one brings trial clients, year two brings mid-sized groups (100-500 members), and year three brings broader opportunities. Consequently, Curative stages entry into new states annually, maintaining a pipeline of markets at different development stages to sustain consistent growth.
Wilson-Serrana reflects on her earlier CFO role at Commonwealth Partners, advising that new CFOs should expect resistance from existing staff and must maintain conviction about organizational direction while staying calm and clear about expectations. She emphasizes that CFOs are hired for independent thinking and should share opinions despite potential disagreement with leadership.
On the broader healthcare mission, Wilson-Serrana argues that current system economics prevent engagement in preventive care, ultimately costing society more through crisis-driven healthcare utilization. She positions Curative as addressing this by making preventive care, medication compliance, and early engagement financially frictionless. She notes that studies show even when preventive services are free, confusion about coverage deters utilization—a problem Curative eliminates through transparency and zero copays.
Personally, Wilson-Serrana describes herself as an operational CFO who enjoys learning new areas and fixing operational challenges. She raises seven children while pursuing active hobbies like Tough Mudders and 5Ks. She credits Dale Carnegie's "How to Make Friends and Influence People" and the Wall Street Journal as intellectual influences.
About this episode
<p>When Tami Wilson-Ciranna joined Curative in April 2020, the assignment came with what now looks like a spectacularly optimistic assumption: three months.</p><p>“I met with Fred on a Tuesday and I started on Thursday,” she recalls. Curative was helping respond to COVID-19, and Wilson-Ciranna—who had retired and become bored—figured she would help with the pandemic. Three months became three years. Curative ultimately administered 36 million COVID tests.</p><p>Then came the harder question: What was phase two?</p><p>Curative wanted to remain in health care, but its leaders concluded that influencing care meant becoming the payer. The result was an employer health plan built around zero deductibles and zero copays, with members encouraged to complete an early baseline visit and engage in preventive care. Curative rolled roughly $500 million into starting the insurance business.</p><p>For Wilson-Ciranna, now president and CFO, the experiment is increasingly about what the data says. Medical loss ratios, provider costs, network economics, member behavior and wellness programs all come under scrutiny. Assumptions are expendable: Curative originally thought one health plan would suffice; market feedback convinced it to offer three.credentialing that Wilson-Ciranna says went from six months to 24–48 hours.</p><p>Perhaps that helps explain her operating philosophy: build, measure, fix—and keep moving. For the coming year, that means supporting Curative’s capital needs, expanding its provider network, entering additional states and adding members.</p>
Key Insights
- Curative's market entry strategy requires three-year staging per state: year one brings trial clients, year two brings mid-sized groups (100-500 members), and year three brings broader market opportunities, necessitating simultaneous pipeline development across multiple states rather than sequential geographic focus.
- The company discovered through market feedback that clients required three plan variations (standard PPO, PPO Max with extra benefits, and EPO for in-network only) despite the zero-deductible model eliminating the traditional need for plan differentiation.
- Wilson-Serrana argues that financial barriers to care—including copays on preventive services—create a self-defeating system where people avoid necessary care due to cost uncertainty, with studies showing colonoscopy utilization decreased on copay plans even when the service itself had zero copay due to consumer confusion.
- Placing one drug from each pharmaceutical class at zero copay results in 97% of pharmacy fills occurring at zero cost, and the company maintains zero copay on expensive brand medications without biosimilars because cost barriers cause patients to skip medications essential for preventing crisis hospitalizations.
- AI implementation in credentialing reduced processing time from six months to 24-48 hours by replacing an outsourced Philippines-based operation with an AI agent, demonstrating how automation can address both speed and provider satisfaction in operational processes.
- Wilson-Serrana observed that healthcare utilization patterns proved more predictable than network provider costs; rental networks that charge 30% markups above contracted rates and difficulty engaging smaller providers with market discounts emerged as more challenging variables to model than actual member care-seeking behavior.
- The CFO hiring decision revealed that leadership explicitly stated 'we're paying you for your opinion,' indicating that new CFOs should expect and provide independent analysis despite potential disagreement, as hiring itself signals the organization wants perspectives leadership cannot independently generate.
- Curative's pivot from pandemic testing to health insurance required deploying $500 million in capital reserves primarily to establish and maintain the A- AMBEST financial rating necessary for insurance operations, revealing that regulatory solvency requirements, not operational scaling, determined the minimum capital threshold for market entry.
Topics
Transcript
Support for CFO Thought Leader comes from Salesforce. Unify selling and billing for a seamless customer experience. And OneStream. Trusted data. Faster decisions. Hello, this is Ross Granger, CFO of Nasuni, and you are listening to the CFO Thought Leader podcast. This is episode 1219. podcast. This is episode 1219. We were, you know, we're setting up the company and the insurance company. And there was a large belief by a lot of people that we just needed to be in one state and really work that state and grow that state. And I was like, no, because when you play this out, it takes, I'd talked to a lot of people in the industry and brokers and other things.…
Full transcript available for MurmurCast members
Sign Up to AccessMore from CFO THOUGHT LEADER
1218: Why Pegasystems Is Betting on Work, Not Tokens | Ken Stillwell, CFO, Pegasystems
Ken Stilwell, CFO and COO of Pegasystems, discusses his unconventional career path from public accounting through M&A to becoming a deeply operational CFO who prioritizes business immersion over financial distance. He explains Pega's cloud transition strategy, AI economics, and how Rule 40 fundamentally transformed the company's operations and culture.
2017: A Sharper Portfolio, A Clearer Capital Story | Brittany Cerwin, CFO, Middleby Corporation
Brittany Cerwin, CFO of Middleby Corporation, discusses the company's major portfolio transformation over 18 months, including spinning off its food processing business as a standalone public company and selling 51% of its residential kitchen business to focus exclusively on commercial food service equipment. This strategic narrowing clarifies the company's investor story, simplifies capital allocation, and enables more targeted growth through solution selling and operational excellence initiatives.
People and Places: The Geography of a CFO Career
This bonus episode of CFO Thought Leader explores how geography shapes finance executive careers through five case studies. Rather than treating location as incidental to career progression, the episode demonstrates how cities, regions, and strategic relocations fundamentally influence network-building, industry exposure, family life, and long-term career satisfaction.
2016: Building the Operating System for Agentic Automation | Ryan Roccon, CFO, Zapier
Ryan Rockan, CFO and COO of Zapier, discusses how the company is positioning itself as the operating system for agentic automation by blending deterministic code with AI inference. He shares how Zapier has maintained profitability while aggressively investing in strategic bets, and explains his pivotal "Path to a Billion" plan that drove the company's shift from product-led growth to enterprise sales.
When AI Changes the EPM Decision | David Den Boer, CEO, Column5 Consulting
David Den Boer, CEO of Column5 Consulting, discusses how AI is rapidly transforming enterprise performance management (EPM) and finance operations, arguing that no single technology component can handle finance operations alone and that CFOs must develop comprehensive understanding of how EPM, BI, data platforms, and AI work together. He explains the upcoming EPM Summit in Las Vegas is designed to help finance leaders evaluate competing vendors and understand the full landscape of available solutions.